N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine

N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine Struktur
95259-48-6
CAS-Nr.
95259-48-6
Englisch Name:
N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine
Synonyma:
Nikkomycin QX;N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine;L-Homoserine, (3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-L-valyl-(2S)-2-[(2R,3S,4R,5R)-5-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3,4-dihydroxy-2-furanyl]glycyl- (9CI);(2S)-2-[[(2S)-2-[[(2S,3S,4S)-2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutanoyl]amino]-2-[(2R,3S,4R,5R)-5-(5-formyl-2-oxo-1H-imidazol-3-yl)-3,4-dihydroxyoxolan-2-yl]acetyl]amino]-4-hydroxybutanoic acid
CBNumber:
CB52335758
Summenformel:
C24H32N6O12
Molgewicht:
596.54
MOL-Datei:
95259-48-6.mol

N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine Eigenschaften

Dichte
1.651±0.06 g/cm3(Predicted)
pka
3.06±0.10(Predicted)

Sicherheit

N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine Chemische Eigenschaften,Einsatz,Produktion Methoden

N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate

  • N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxypyridin-2-yl)-L-valyl]-L-glycyl]-L-homoserine
  • Nikkomycin QX
  • (2S)-2-[[(2S)-2-[[(2S,3S,4S)-2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutanoyl]amino]-2-[(2R,3S,4R,5R)-5-(5-formyl-2-oxo-1H-imidazol-3-yl)-3,4-dihydroxyoxolan-2-yl]acetyl]amino]-4-hydroxybutanoic acid
  • L-Homoserine, (3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-L-valyl-(2S)-2-[(2R,3S,4R,5R)-5-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3,4-dihydroxy-2-furanyl]glycyl- (9CI)
  • 95259-48-6
Copyright 2019 © ChemicalBook. All rights reserved